Osteoporotic OA: a reasonable target for bone-acting agents

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

(2012) Jean-Yves Reginster et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical relevance of bone marrow lesions in OA

(2012) C. Kent Kwoh   Nature Reviews Rheumatology

Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis

(2011) M. Bellido et al.   OSTEOARTHRITIS AND CARTILAGE

Bone and cartilage in osteoarthritis: is what's best for one good or bad for the other?

(2010) Steven R Goldring et al.   ARTHRITIS RESEARCH & THERAPY

Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis

(2010) Miriam Bellido et al.   ARTHRITIS RESEARCH & THERAPY

Subchondral bone marrow lesions are highly associated with, and predict subchondral bone attrition longitudinally: the MOST study

(2009) F.W. Roemer et al.   OSTEOARTHRITIS AND CARTILAGE

Primary Osteoarthritis No Longer Primary: Three Subsets with Distinct Etiological, Clinical, and Therapeutic Characteristics

(2009) Gabriel Herrero-Beaumont et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM